A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance
- PMID: 2137615
- PMCID: PMC53500
- DOI: 10.1073/pnas.87.4.1486
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance
Abstract
A highly immunogenic C3H-derived UV-induced tumor was cotransfected with a murine transforming growth factor type beta 1 (TGF-beta 1) cDNA and a neomycin-resistance gene. Stable clones were isolated and used in vitro and in vivo to determine the effects of endogenously produced TGF-beta on cytolytic T-lymphocyte (CTL) responses. Tumor cells producing TGF-beta, though retaining expression for class I major histocompatibility complex molecules and the tumor-specific antigen, did not stimulate primary CTL responses in vitro and were not effective in vivo for directly stimulating primary CTL or in priming for CTL responses. Furthermore, TGF-beta-producing tumors grew progressively in transiently immunosuppressed mice without losing the tumor antigen; thus, TGF-beta produced by tumors may promote escape from immune surveillance.
Similar articles
-
Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.Tissue Antigens. 1996 May;47(5):399-407. doi: 10.1111/j.1399-0039.1996.tb02575.x. Tissue Antigens. 1996. PMID: 8795140
-
Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.Cancer Res. 1990 Jun 1;50(11):3159-66. Cancer Res. 1990. PMID: 2185882
-
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.Cancer Res. 1992 Mar 15;52(6):1386-92. Cancer Res. 1992. PMID: 1531782
-
MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.Semin Cancer Biol. 1991 Oct;2(5):321-8. Semin Cancer Biol. 1991. PMID: 1837738 Review.
-
Cycling in equilibrium or formed from noncycling cell transitions in tissue aging, immunological surveillance, transformation, and tumor growth.Int Rev Cytol. 1981;70:1-25. doi: 10.1016/s0074-7696(08)61129-8. Int Rev Cytol. 1981. PMID: 7014503 Review. No abstract available.
Cited by
-
Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells.J Neurooncol. 1999 May;43(1):27-34. doi: 10.1023/a:1006289901702. J Neurooncol. 1999. PMID: 10448868
-
Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy.Indian J Hum Genet. 2009 Jan;15(1):3-8. doi: 10.4103/0971-6866.50862. Indian J Hum Genet. 2009. PMID: 20407642 Free PMC article.
-
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma.Br J Cancer. 1998 May;77(9):1492-4. doi: 10.1038/bjc.1998.245. Br J Cancer. 1998. PMID: 9652767 Free PMC article.
-
Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.Immunology. 2015 Feb;144(2):186-96. doi: 10.1111/imm.12387. Immunology. 2015. PMID: 25243729 Free PMC article. Review.
-
Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.Front Immunol. 2015 Oct 8;6:505. doi: 10.3389/fimmu.2015.00505. eCollection 2015. Front Immunol. 2015. PMID: 26500646 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources